Mergers & Acquisitions ·
DataMEDS terminates $0 LOI to acquire IP and controlling interest in Tollo Health from EOS, Scilex
MEDSDataMeds AI, Inc.
DataMEDS AI terminated its Second Amended and Restated Letter of Intent with EOS Technology Holdings, Scilex Holding Company, Datavault AI Inc., HealthBridge Advisors, Tollo Health, and REBOOT Health AI. The agreement contemplated acquiring intellectual property assets, expanding a PharmacyChain license, obtaining a controlling interest in Tollo Health, and establishing IP licensing arrangements in exchange for common stock. Termination was effective immediately due to market conditions, with no fees or obligations owed by DataMEDS. Existing exclusive licenses with REBOOT and Datavault remain in full force. The company operates in the healthcare sector, integrating health information technology, AI platforms, blockchain-enabled smart contracts, pharmacy services, and clinical molecular diagnostics.